181 related articles for article (PubMed ID: 36031725)
1. Neurocognitive functioning in children with sickle cell anemia and history of abnormal transcranial doppler ultrasonography.
Longoria JN; Wang W; Kang G; Gossett J; Krull K; King AA; Raches D; Schreiber J; Heitzer AM; Hankins JS
Pediatr Blood Cancer; 2022 Nov; 69(11):e29943. PubMed ID: 36031725
[TBL] [Abstract][Full Text] [Related]
2. Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial.
Ware RE; Davis BR; Schultz WH; Brown RC; Aygun B; Sarnaik S; Odame I; Fuh B; George A; Owen W; Luchtman-Jones L; Rogers ZR; Hilliard L; Gauger C; Piccone C; Lee MT; Kwiatkowski JL; Jackson S; Miller ST; Roberts C; Heeney MM; Kalfa TA; Nelson S; Imran H; Nottage K; Alvarez O; Rhodes M; Thompson AA; Rothman JA; Helton KJ; Roberts D; Coleman J; Bonner MJ; Kutlar A; Patel N; Wood J; Piller L; Wei P; Luden J; Mortier NA; Stuber SE; Luban NLC; Cohen AR; Pressel S; Adams RJ
Lancet; 2016 Feb; 387(10019):661-670. PubMed ID: 26670617
[TBL] [Abstract][Full Text] [Related]
3. Changes in Transcranial Doppler Flow Velocities in Children with Sickle Cell Disease: The Impact of Hydroxyurea Therapy.
Adegoke SA; Macedo-Campos RS; Braga JAP; Figueiredo MS; Silva GS
J Stroke Cerebrovasc Dis; 2018 Feb; 27(2):425-431. PubMed ID: 29056404
[TBL] [Abstract][Full Text] [Related]
4. Hydroxycarbamide treatment reduces transcranial Doppler velocity in the absence of transfusion support in children with sickle cell anaemia, elevated transcranial Doppler velocity, and cerebral vasculopathy: the EXTEND trial.
Rankine-Mullings A; Reid M; Soares D; Taylor-Bryan C; Wisdom-Phipps M; Aldred K; Latham T; Schultz WH; Knight-Madden J; Badaloo A; Lane A; Adams RJ; Ware RE
Br J Haematol; 2021 Nov; 195(4):612-620. PubMed ID: 34291449
[TBL] [Abstract][Full Text] [Related]
5. Hydroxyurea therapy lowers transcranial Doppler flow velocities in children with sickle cell anemia.
Zimmerman SA; Schultz WH; Burgett S; Mortier NA; Ware RE
Blood; 2007 Aug; 110(3):1043-7. PubMed ID: 17429008
[TBL] [Abstract][Full Text] [Related]
6. The clinical effectiveness and cost-effectiveness of primary stroke prevention in children with sickle cell disease: a systematic review and economic evaluation.
Cherry MG; Greenhalgh J; Osipenko L; Venkatachalam M; Boland A; Dundar Y; Marsh K; Dickson R; Rees DC
Health Technol Assess; 2012; 16(43):1-129. PubMed ID: 23140544
[TBL] [Abstract][Full Text] [Related]
7. What drives transcranial Doppler velocity improvement in paediatric sickle cell anaemia: analysis from the Sickle Cell Clinical Research and Intervention Program (SCCRIP) longitudinal cohort study.
Estepp JH; Cong Z; Agodoa I; Kang G; Ding J; McCarville MB; Hankins JS; Wang WC
Br J Haematol; 2021 Jul; 194(2):463-468. PubMed ID: 34131902
[TBL] [Abstract][Full Text] [Related]
8. Transcranial Doppler velocity and brain MRI/MRA changes in children with sickle cell anemia on chronic transfusions to prevent primary stroke.
Sheehan VA; Hansbury EN; Smeltzer MP; Fortner G; McCarville MB; Aygun B
Pediatr Blood Cancer; 2013 Sep; 60(9):1499-502. PubMed ID: 23625812
[TBL] [Abstract][Full Text] [Related]
9. Hydroxyurea lowers transcranial Doppler flow velocities in children with sickle cell anaemia in a Nigerian cohort.
Lagunju I; Brown BJ; Sodeinde O
Pediatr Blood Cancer; 2015 Sep; 62(9):1587-91. PubMed ID: 25847050
[TBL] [Abstract][Full Text] [Related]
10. Interventions for preventing silent cerebral infarcts in people with sickle cell disease.
Estcourt LJ; Kimber C; Hopewell S; Trivella M; Doree C; Abboud MR
Cochrane Database Syst Rev; 2020 Apr; 4(4):CD012389. PubMed ID: 32250453
[TBL] [Abstract][Full Text] [Related]
11. Burden of neurological and neurocognitive impairment in pediatric sickle cell anemia in Uganda (BRAIN SAFE): a cross-sectional study.
Green NS; Munube D; Bangirana P; Buluma LR; Kebirungi B; Opoka R; Mupere E; Kasirye P; Kiguli S; Birabwa A; Kawooya MS; Lubowa SK; Sekibira R; Kayongo E; Hume H; Elkind M; Peng W; Li G; Rosano C; LaRussa P; Minja FJ; Boehme A; Idro R
BMC Pediatr; 2019 Oct; 19(1):381. PubMed ID: 31651270
[TBL] [Abstract][Full Text] [Related]
12. Annual stroke incidence in Nigerian children with sickle cell disease and elevated TCD velocities treated with hydroxyurea.
Lagunju I; Brown BJ; Oyinlade AO; Asinobi A; Ibeh J; Esione A; Sodeinde OO
Pediatr Blood Cancer; 2019 Mar; 66(3):e27252. PubMed ID: 29797633
[TBL] [Abstract][Full Text] [Related]
13. Effect of transfusion therapy on transcranial Doppler ultrasonography velocities in children with sickle cell disease.
Kwiatkowski JL; Yim E; Miller S; Adams RJ;
Pediatr Blood Cancer; 2011 May; 56(5):777-82. PubMed ID: 21370410
[TBL] [Abstract][Full Text] [Related]
14. Can peak systolic velocities be used for prediction of stroke in sickle cell anemia?
Jones A; Granger S; Brambilla D; Gallagher D; Vichinsky E; Woods G; Berman B; Roach S; Nichols F; Adams RJ
Pediatr Radiol; 2005 Jan; 35(1):66-72. PubMed ID: 15517239
[TBL] [Abstract][Full Text] [Related]
15. Association of Matched Sibling Donor Hematopoietic Stem Cell Transplantation With Transcranial Doppler Velocities in Children With Sickle Cell Anemia.
Bernaudin F; Verlhac S; Peffault de Latour R; Dalle JH; Brousse V; Petras E; Thuret I; Paillard C; Neven B; Galambrun C; Divialle-Doumdo L; Pondarré C; Guitton C; Missud F; Runel C; Jubert C; Elana G; Ducros-Miralles E; Drain E; Taïeb O; Arnaud C; Kamdem A; Malric A; Elmaleh-Bergès M; Vasile M; Leveillé E; Socié G; Chevret S;
JAMA; 2019 Jan; 321(3):266-276. PubMed ID: 30667500
[TBL] [Abstract][Full Text] [Related]
16. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography.
Adams RJ; McKie VC; Hsu L; Files B; Vichinsky E; Pegelow C; Abboud M; Gallagher D; Kutlar A; Nichols FT; Bonds DR; Brambilla D
N Engl J Med; 1998 Jul; 339(1):5-11. PubMed ID: 9647873
[TBL] [Abstract][Full Text] [Related]
17. Prevention of conversion to abnormal transcranial Doppler with hydroxyurea in sickle cell anemia: A Phase III international randomized clinical trial.
Hankins JS; McCarville MB; Rankine-Mullings A; Reid ME; Lobo CL; Moura PG; Ali S; Soares DP; Aldred K; Jay DW; Aygun B; Bennett J; Kang G; Goldsmith JC; Smeltzer MP; Boyett JM; Ware RE
Am J Hematol; 2015 Dec; 90(12):1099-105. PubMed ID: 26414435
[TBL] [Abstract][Full Text] [Related]
18. Transcranial Doppler ultrasonography and neurocognitive functioning in children with sickle cell disease.
Kral MC; Brown RT; Nietert PJ; Abboud MR; Jackson SM; Hynd GW
Pediatrics; 2003 Aug; 112(2):324-31. PubMed ID: 12897282
[TBL] [Abstract][Full Text] [Related]
19. The other side of abnormal: a case series of low transcranial Doppler velocities associated with stroke in children with sickle cell disease.
Buchanan ID; James-Herry A; Osunkwo I
J Pediatr Hematol Oncol; 2013 Oct; 35(7):543-6. PubMed ID: 23211694
[TBL] [Abstract][Full Text] [Related]
20. Transcranial Doppler (TCD) screening for stroke prevention in sickle cell anemia: pitfalls in technique variation.
Bulas DI; Jones A; Seibert JJ; Driscoll C; O'Donnell R; Adams RJ
Pediatr Radiol; 2000 Nov; 30(11):733-8. PubMed ID: 11100487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
